703 posters,  63 sessions,  7 topics,  1978 authors 
ePostersLive® by SciGen® Technologies S.A. All rights reserved.

5158
The first case report of bupivacaine liposome injectable suspension usage for Supraorbital and Supratrochlear nerve blocks to treat V1 distribution Herpes Zoster neuralgia
Session: EX-09
Fri, April 20, 7:40-7:50 am
Screen 2

Please note, medically challenging cases are removed three months after the meeting and scientific abstracts after three years.

Poster Presenter
Affiliations

Rate

No votes yet

The first case report of bupivacaine liposome injectable suspension usage for Supraorbital and Supratrochlear nerve blocks to treat V1 distribution Herpes Zoster neuralgia

We report the case of an 81 year old female transferred from an outside hospital with acute herpes zoster eruption in the left V1 distribution with severe associated pain refractory to a multimodal medication regimen including intravenous hydromorphone, membrane stabilizing analgesics, and antiviral therapy. Additionally, she had superficial ocular involvement on the affected side. In the week prior to admission, the patient received daily supraorbital/supratrochlear nerve blocks with bupivacaine and dexamethasone to treat her acute pain with >50% pain relief but lasting only 6-8 hours. Her condition was complicated by over-sedation from systemic analgesics. In an effort to prolong her pain relief and reduce the reliance on systemic medications, we planned to conduct nerve blocks with bupivacaine liposome injectable suspension (preparation: 266mg in 20 ml)

 

Enter Poster ID (e.gGoNextPreviousCurrent